Medicina
Departamento
Dresden University of Technology
Dresde, AlemaniaPublicaciones en colaboración con investigadores/as de Dresden University of Technology (14)
2023
2020
-
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness
Cancer Research, Vol. 80, Núm. 3, pp. 624-638
-
The clinical, histologic, and genotypic spectrum of SEPN1-related myopathy: A case series
Neurology, Vol. 95, Núm. 11, pp. e1512-e1527
2019
-
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
Nature Communications, Vol. 10, Núm. 1
-
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1242-1248
-
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort
Annals of the Rheumatic Diseases, Vol. 78, Núm. 5, pp. 648-656
-
Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Radiotherapy and Oncology, Vol. 133, pp. 163-166
2017
2016
-
Balance between sodium and calcium currents underlying chronic atrial fibrillation termination: An in silico intersubject variability study
Heart Rhythm, Vol. 13, Núm. 12, pp. 2358-2365
-
Male breast cancer in BRCA1 and BRCA2 mutation carriers: Pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
Breast Cancer Research, Vol. 18, Núm. 1
2015
-
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database
Annals of the Rheumatic Diseases, Vol. 74, Núm. 6, pp. 1124-1131
2014
2012
-
Improving patient-physician dialog: Commentary on the results of the MS Choices survey
Patient Preference and Adherence
2009
-
Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: A randomized, blinded, phase 3 trial
Journal of Bone and Mineral Research, Vol. 24, Núm. 1, pp. 153-161